Par CentralPharma Communications SIA (Reģ. Nr.40003521795) medikamenta Epclusa (Sofosbuvirum/ Velpatasvirum) apvalkotas tabletes 400/100mg Nr.28 iekļaušanu Kompensējamo zāļu sarakstā

In force· 3 articles· Issued by: Nacionālais veselības dienests· In force from: Thu Feb 01
Verify on the source (likumi.lv)

Reference only — not legal advice. The corpus mirrors statutory text (including repealed editions); a result may be superseded. Always verify against the current consolidated version on likumi.lv before relying on it.

Par CentralPharma Communications SIA (Reģ. Nr.40003521795) medikamenta Epclusa (Sofosbuvirum/ Velpatasvirum) apvalkotas tabletes 400/100mg Nr.28 iekļaušanu Kompensējamo zāļu sarakstā · AI Martins